BARINTHUS BIOTHERAPEUTICS PL(NASDAQ:BRNS) stock News

BRNS Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Chartmill - Mentions: CLRO OPEN RDHL BNED ...

Which stocks are experiencing notable movement on Monday?

13 days ago - By: Benzinga - Mentions: RFL CYCC CRL ONMD ...

12 Health Care Stocks Moving In Monday's After-Market Session

18 days ago - By: Benzinga - Mentions: CYCC SSII ONCO CUE ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

a month ago - By: ACCESS Newswire - Mentions: MNRG.CA OPHC XHLD ROLR ...

Q2 Virtual Investor Summit: Presentations Available Now

2 months ago - By: ACCESS Newswire

Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025

3 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

3 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

5 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

5 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

5 months ago - By: ACCESS Newswire - Mentions: DRTS GIFT VOXR FEMY ...

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

5 months ago - By: ACCESS Newswire

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11

7 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

7 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

8 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer

8 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer

9 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

9 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

9 months ago - By: Barinthus Biotherapeutics - Mentions: ABUS

Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

9 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

9 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results

9 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences

10 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

10 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

10 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

10 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

a year ago - By: InvestorPlace